↓ Skip to main content

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, November 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis
Published in
Frontiers in Cardiovascular Medicine, November 2022
DOI 10.3389/fcvm.2022.989574
Pubmed ID
Authors

Menglu Liu, Panpan Xia, Ziqi Tan, Tiangang Song, Kaibo Mei, Jingfeng Wang, Jianyong Ma, Yuan Jiang, Jing Zhang, Yujie Zhao, Peng Yu, Xiao Liu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 12%
Researcher 2 12%
Student > Bachelor 2 12%
Unspecified 1 6%
Other 1 6%
Other 1 6%
Unknown 8 47%
Readers by discipline Count As %
Medicine and Dentistry 5 29%
Nursing and Health Professions 2 12%
Unspecified 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#20,498,776
of 23,063,209 outputs
Outputs from Frontiers in Cardiovascular Medicine
#4,348
of 6,975 outputs
Outputs of similar age
#350,355
of 441,089 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#577
of 965 outputs
Altmetric has tracked 23,063,209 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,975 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,089 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 965 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.